Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Inflamm Res ; 51(3): 144-53, 2002 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-12005205

RESUMO

OBJECTIVE AND DESIGN: In this study we investigated the chemotactic mediators involved in the Sephadex-induced eosinophil migration into the peritoneal cavities of rats and mice, and which resident peritoneal cells release these mediators. MATERIALS AND METHODS: Sephadex suspension was injected into the peritoneal cavities of rats or mice which were pretreated, or not, with specific drugs that inhibit synthesis or production of the inflammatory mediators and eosinophil chemotactic activities were observed. To investigate the role of resident peritoneal cells as a source of these chemotactic factors, the macrophage population was enhanced or the mast cell population was depleted. The resident cells were also stimulated, in vitro, with Sephadex and the chemotactic activity of the supernatants was determined. RESULTS: Sephadex induced dose and time dependent eosinophil migration in rats and mouse, which were inhibited by dexamethasone and MK 886. BN 52021 only affected the eosinophil migration into the mouse peritoneal cavity. An increase in the macrophage population did not alter the eosinophil migration induced by Sephadex in rat or mouse. However, mast cell population depletion reduced eosinophil migration in rats, but did not alter the migration in mice. Sephadex-stimulated rat mast cells released an eosinophil chemotactic factor whose release was inhibited by dexamethasone and MK 886. Anti-TNF-alpha and anti-IL-8 Abs inhibited the chemotactic activity of the mast cell supernatant. CONCLUSION: Sephadex-induced eosinophil migration into the rat peritoneal cavity is dependent on mast cells, which release LTB4, TNF-alpha and CINC-1. Conversely, Sephadex-induced eosinophil migration into the mouse peritoneal cavity is mediated by PAF and LTB4, which are not released from resident macrophages or mast cells.


Assuntos
Quimiocinas CXC , Dextranos/farmacologia , Eosinófilos/efeitos dos fármacos , Interleucina-8/fisiologia , Leucotrieno B4/fisiologia , Mastócitos/fisiologia , Cavidade Peritoneal/citologia , Fator de Ativação de Plaquetas/fisiologia , Fator de Necrose Tumoral alfa/fisiologia , Animais , Movimento Celular/efeitos dos fármacos , Quimiocina CXCL1 , Quimiocinas/fisiologia , Fatores Quimiotáticos/fisiologia , Relação Dose-Resposta a Droga , Eosinófilos/fisiologia , Peptídeos e Proteínas de Sinalização Intercelular/fisiologia , Masculino , Camundongos , Ratos , Ratos Wistar
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA